Jennifer joined the team in 2017. She focuses on an array of drug pricing-related analyses, with her current projects analyzing the supply chain dynamics and regulatory processes in the US and abroad, profiling Medicare Part D formularies, and critically reviewing key industry talking points. She also oversees day-to-day operations of program grants.
Prior to drug pricing, Jennifer supported the Epidemiology Service at MSKCC on projects specific to the cost-effectiveness analyses of colorectal cancer screening. She holds an MPH in epidemiology and pharmaceuticals management from Boston University School of Public Health, and a BS in anthropology from the University of California, Riverside.
